R'SUD MEDICAL : revenue, balance sheet and financial ratios

R'SUD MEDICAL is a French company founded 23 years ago, specialized in the sector Location et location-bail d'autres biens personnels et domestiques. Based in GREASQUE (13850), this company of category PME shows in 2022 a revenue of 9.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - R'SUD MEDICAL (SIREN 443621685)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 9 604 392 € 10 372 478 € 11 913 115 € 12 059 200 € 10 604 413 € 10 656 217 € N/C
Net income 429 414 € 511 163 € 461 662 € 928 871 € 1 353 734 € 1 047 796 € 1 174 041 € 561 862 € 1 230 541 €
EBITDA N/C N/C 1 971 668 € 2 668 512 € 3 652 010 € 3 273 590 € 3 128 451 € 2 548 699 € -7 171 042 €
Net margin N/C N/C 4.8% 9.0% 11.4% 8.7% 11.1% 5.3% N/C

Revenue and income statement

In 2024, R'SUD MEDICAL generates positive net income of 429 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 1.2 M€ -> 429 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

429 414 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 80%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

79.853%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.974%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

28.4%

Solvency indicators evolution
R'SUD MEDICAL

Sector positioning

Debt ratio
79.85 2024
2022
2023
2024
Q1: 0.0
Med: 9.81
Q3: 79.47
Average +7 pts over 3 years

In 2024, the debt ratio of R'SUD MEDICAL (79.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
37.97% 2024
2022
2023
2024
Q1: 5.79%
Med: 33.76%
Q3: 60.35%
Good

In 2024, the financial autonomy of R'SUD MEDICAL (38.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
1.53 years 2022
2022
Q1: 0.0 years
Med: 0.03 years
Q3: 1.43 years
Average

In 2022, the repayment capacity of R'SUD MEDICAL (1.53) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 142.92. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

142.921

Liquidity indicators evolution
R'SUD MEDICAL

Sector positioning

Liquidity ratio
142.92 2024
2022
2023
2024
Q1: 106.8
Med: 176.44
Q3: 303.96
Average

In 2024, the liquidity ratio of R'SUD MEDICAL (142.92) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
2.73x 2022
2022
Q1: 0.0x
Med: 0.04x
Q3: 1.23x
Excellent

In 2022, the interest coverage of R'SUD MEDICAL (2.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
R'SUD MEDICAL

Positioning of R'SUD MEDICAL in its sector

Comparison with sector Location et location-bail d'autres biens personnels et domestiques

Valuation estimate

Based on 69 transactions of similar company sales (all years), the value of R'SUD MEDICAL is estimated at 1 725 981 € (range 675 382€ - 5 251 836€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
69 tx
675k€ 1725k€ 5251k€
1 725 981 € Range: 675 382€ - 5 251 836€
NAF 5 all-time

Valuation method used

Net Income Multiple
429 414 € × 4.0x = 1 725 981 €
Range: 675 382€ - 5 251 836€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Location et location-bail d'autres biens personnels et domestiques)

Compare R'SUD MEDICAL with other companies in the same sector:

Frequently asked questions about R'SUD MEDICAL

What is the revenue of R'SUD MEDICAL ?

The revenue of R'SUD MEDICAL in 2022 is 9.6 M€.

Is R'SUD MEDICAL profitable?

Yes, R'SUD MEDICAL generated a net profit of 429 k€ in 2024.

Where is the headquarters of R'SUD MEDICAL ?

The headquarters of R'SUD MEDICAL is located in GREASQUE (13850), in the department Bouches-du-Rhone.

Where to find the tax return of R'SUD MEDICAL ?

The tax return of R'SUD MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does R'SUD MEDICAL operate?

R'SUD MEDICAL operates in the sector Location et location-bail d'autres biens personnels et domestiques (NAF code 77.29Z). See the 'Sector positioning' section above to compare the company with its competitors.